Global Polyethylene Glycol (PEG) in Medical 麻豆原创 Research Report 2023

Publication ID:

PB504240759

Publication Date:

May 3, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Polyethylene Glycol (PEG) in Medical market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Polyethylene Glycol (PEG) in Medical is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Polyethylene Glycol (PEG) in Medical is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Polyethylene Glycol (PEG) in Medical include BASF, Dow Chemical, Croda, Clariant, Ineos, India Glycols, Shandong Ruisheng, Jiangxi Yipusheng and Liaoning Huaxing Chemical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polyethylene Glycol (PEG) in Medical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polyethylene Glycol (PEG) in Medical.
The Polyethylene Glycol (PEG) in Medical market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Polyethylene Glycol (PEG) in Medical market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polyethylene Glycol (PEG) in Medical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BASF
Dow Chemical
Croda
Clariant
Ineos
India Glycols
Shandong Ruisheng
Jiangxi Yipusheng
Liaoning Huaxing Chemical
Petronas Chemicals
Segment by Type
Mw (锛�1000)
Mw (1000-10000)
Segment by Application
Tablets
Capsules
Liquids
Injectables
Topicals
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Polyethylene Glycol (PEG) in Medical manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Polyethylene Glycol (PEG) in Medical by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Polyethylene Glycol (PEG) in Medical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Polyethylene Glycol (PEG) in Medical 麻豆原创 Overview
1.1 Product Definition
1.2 Polyethylene Glycol (PEG) in Medical Segment by Type
1.2.1 Global Polyethylene Glycol (PEG) in Medical 麻豆原创 Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Mw (锛�1000)
1.2.3 Mw (1000-10000)
1.3 Polyethylene Glycol (PEG) in Medical Segment by Application
1.3.1 Global Polyethylene Glycol (PEG) in Medical 麻豆原创 Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Liquids
1.3.5 Injectables
1.3.6 Topicals
1.3.7 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Polyethylene Glycol (PEG) in Medical Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Polyethylene Glycol (PEG) in Medical Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Polyethylene Glycol (PEG) in Medical Production Estimates and Forecasts (2018-2029)
1.4.4 Global Polyethylene Glycol (PEG) in Medical 麻豆原创 Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Polyethylene Glycol (PEG) in Medical Production 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Polyethylene Glycol (PEG) in Medical Production Value 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Key Players of Polyethylene Glycol (PEG) in Medical, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Polyethylene Glycol (PEG) in Medical 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Polyethylene Glycol (PEG) in Medical Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Polyethylene Glycol (PEG) in Medical, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Polyethylene Glycol (PEG) in Medical, Product Offered and Application
2.8 Global Key Manufacturers of Polyethylene Glycol (PEG) in Medical, Date of Enter into This Industry
2.9 Polyethylene Glycol (PEG) in Medical 麻豆原创 Competitive Situation and Trends
2.9.1 Polyethylene Glycol (PEG) in Medical 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Polyethylene Glycol (PEG) in Medical Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Polyethylene Glycol (PEG) in Medical Production by Region
3.1 Global Polyethylene Glycol (PEG) in Medical Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Polyethylene Glycol (PEG) in Medical Production Value by Region (2018-2029)
3.2.1 Global Polyethylene Glycol (PEG) in Medical Production Value 麻豆原创 Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Polyethylene Glycol (PEG) in Medical by Region (2024-2029)
3.3 Global Polyethylene Glycol (PEG) in Medical Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Polyethylene Glycol (PEG) in Medical Production by Region (2018-2029)
3.4.1 Global Polyethylene Glycol (PEG) in Medical Production 麻豆原创 Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Polyethylene Glycol (PEG) in Medical by Region (2024-2029)
3.5 Global Polyethylene Glycol (PEG) in Medical 麻豆原创 Price Analysis by Region (2018-2023)
3.6 Global Polyethylene Glycol (PEG) in Medical Production and Value, Year-over-Year Growth
3.6.1 North America Polyethylene Glycol (PEG) in Medical Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Polyethylene Glycol (PEG) in Medical Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Polyethylene Glycol (PEG) in Medical Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Polyethylene Glycol (PEG) in Medical Production Value Estimates and Forecasts (2018-2029)
4 Polyethylene Glycol (PEG) in Medical Consumption by Region
4.1 Global Polyethylene Glycol (PEG) in Medical Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Polyethylene Glycol (PEG) in Medical Consumption by Region (2018-2029)
4.2.1 Global Polyethylene Glycol (PEG) in Medical Consumption by Region (2018-2023)
4.2.2 Global Polyethylene Glycol (PEG) in Medical Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Polyethylene Glycol (PEG) in Medical Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Polyethylene Glycol (PEG) in Medical Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Polyethylene Glycol (PEG) in Medical Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Polyethylene Glycol (PEG) in Medical Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Polyethylene Glycol (PEG) in Medical Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Polyethylene Glycol (PEG) in Medical Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Polyethylene Glycol (PEG) in Medical Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Polyethylene Glycol (PEG) in Medical Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Polyethylene Glycol (PEG) in Medical Production by Type (2018-2029)
5.1.1 Global Polyethylene Glycol (PEG) in Medical Production by Type (2018-2023)
5.1.2 Global Polyethylene Glycol (PEG) in Medical Production by Type (2024-2029)
5.1.3 Global Polyethylene Glycol (PEG) in Medical Production 麻豆原创 Share by Type (2018-2029)
5.2 Global Polyethylene Glycol (PEG) in Medical Production Value by Type (2018-2029)
5.2.1 Global Polyethylene Glycol (PEG) in Medical Production Value by Type (2018-2023)
5.2.2 Global Polyethylene Glycol (PEG) in Medical Production Value by Type (2024-2029)
5.2.3 Global Polyethylene Glycol (PEG) in Medical Production Value 麻豆原创 Share by Type (2018-2029)
5.3 Global Polyethylene Glycol (PEG) in Medical Price by Type (2018-2029)
6 Segment by Application
6.1 Global Polyethylene Glycol (PEG) in Medical Production by Application (2018-2029)
6.1.1 Global Polyethylene Glycol (PEG) in Medical Production by Application (2018-2023)
6.1.2 Global Polyethylene Glycol (PEG) in Medical Production by Application (2024-2029)
6.1.3 Global Polyethylene Glycol (PEG) in Medical Production 麻豆原创 Share by Application (2018-2029)
6.2 Global Polyethylene Glycol (PEG) in Medical Production Value by Application (2018-2029)
6.2.1 Global Polyethylene Glycol (PEG) in Medical Production Value by Application (2018-2023)
6.2.2 Global Polyethylene Glycol (PEG) in Medical Production Value by Application (2024-2029)
6.2.3 Global Polyethylene Glycol (PEG) in Medical Production Value 麻豆原创 Share by Application (2018-2029)
6.3 Global Polyethylene Glycol (PEG) in Medical Price by Application (2018-2029)
7 Key Companies Profiled
7.1 BASF
7.1.1 BASF Polyethylene Glycol (PEG) in Medical Corporation Information
7.1.2 BASF Polyethylene Glycol (PEG) in Medical Product Portfolio
7.1.3 BASF Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.1.4 BASF Main Business and 麻豆原创s Served
7.1.5 BASF Recent Developments/Updates
7.2 Dow Chemical
7.2.1 Dow Chemical Polyethylene Glycol (PEG) in Medical Corporation Information
7.2.2 Dow Chemical Polyethylene Glycol (PEG) in Medical Product Portfolio
7.2.3 Dow Chemical Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Dow Chemical Main Business and 麻豆原创s Served
7.2.5 Dow Chemical Recent Developments/Updates
7.3 Croda
7.3.1 Croda Polyethylene Glycol (PEG) in Medical Corporation Information
7.3.2 Croda Polyethylene Glycol (PEG) in Medical Product Portfolio
7.3.3 Croda Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Croda Main Business and 麻豆原创s Served
7.3.5 Croda Recent Developments/Updates
7.4 Clariant
7.4.1 Clariant Polyethylene Glycol (PEG) in Medical Corporation Information
7.4.2 Clariant Polyethylene Glycol (PEG) in Medical Product Portfolio
7.4.3 Clariant Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Clariant Main Business and 麻豆原创s Served
7.4.5 Clariant Recent Developments/Updates
7.5 Ineos
7.5.1 Ineos Polyethylene Glycol (PEG) in Medical Corporation Information
7.5.2 Ineos Polyethylene Glycol (PEG) in Medical Product Portfolio
7.5.3 Ineos Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Ineos Main Business and 麻豆原创s Served
7.5.5 Ineos Recent Developments/Updates
7.6 India Glycols
7.6.1 India Glycols Polyethylene Glycol (PEG) in Medical Corporation Information
7.6.2 India Glycols Polyethylene Glycol (PEG) in Medical Product Portfolio
7.6.3 India Glycols Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.6.4 India Glycols Main Business and 麻豆原创s Served
7.6.5 India Glycols Recent Developments/Updates
7.7 Shandong Ruisheng
7.7.1 Shandong Ruisheng Polyethylene Glycol (PEG) in Medical Corporation Information
7.7.2 Shandong Ruisheng Polyethylene Glycol (PEG) in Medical Product Portfolio
7.7.3 Shandong Ruisheng Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Shandong Ruisheng Main Business and 麻豆原创s Served
7.7.5 Shandong Ruisheng Recent Developments/Updates
7.8 Jiangxi Yipusheng
7.8.1 Jiangxi Yipusheng Polyethylene Glycol (PEG) in Medical Corporation Information
7.8.2 Jiangxi Yipusheng Polyethylene Glycol (PEG) in Medical Product Portfolio
7.8.3 Jiangxi Yipusheng Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Jiangxi Yipusheng Main Business and 麻豆原创s Served
7.7.5 Jiangxi Yipusheng Recent Developments/Updates
7.9 Liaoning Huaxing Chemical
7.9.1 Liaoning Huaxing Chemical Polyethylene Glycol (PEG) in Medical Corporation Information
7.9.2 Liaoning Huaxing Chemical Polyethylene Glycol (PEG) in Medical Product Portfolio
7.9.3 Liaoning Huaxing Chemical Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Liaoning Huaxing Chemical Main Business and 麻豆原创s Served
7.9.5 Liaoning Huaxing Chemical Recent Developments/Updates
7.10 Petronas Chemicals
7.10.1 Petronas Chemicals Polyethylene Glycol (PEG) in Medical Corporation Information
7.10.2 Petronas Chemicals Polyethylene Glycol (PEG) in Medical Product Portfolio
7.10.3 Petronas Chemicals Polyethylene Glycol (PEG) in Medical Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Petronas Chemicals Main Business and 麻豆原创s Served
7.10.5 Petronas Chemicals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Polyethylene Glycol (PEG) in Medical Industry Chain Analysis
8.2 Polyethylene Glycol (PEG) in Medical Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Polyethylene Glycol (PEG) in Medical Production Mode & Process
8.4 Polyethylene Glycol (PEG) in Medical Sales and 麻豆原创ing
8.4.1 Polyethylene Glycol (PEG) in Medical Sales Channels
8.4.2 Polyethylene Glycol (PEG) in Medical Distributors
8.5 Polyethylene Glycol (PEG) in Medical Customers
9 Polyethylene Glycol (PEG) in Medical 麻豆原创 Dynamics
9.1 Polyethylene Glycol (PEG) in Medical Industry Trends
9.2 Polyethylene Glycol (PEG) in Medical 麻豆原创 Drivers
9.3 Polyethylene Glycol (PEG) in Medical 麻豆原创 Challenges
9.4 Polyethylene Glycol (PEG) in Medical 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

BASF
Dow Chemical
Croda
Clariant
Ineos
India Glycols
Shandong Ruisheng
Jiangxi Yipusheng
Liaoning Huaxing Chemical
Petronas Chemicals

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.